Stay updated on NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.

Latest updates to the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe date has been updated from February 3, 2025, to March 3, 2025.SummaryDifference0.3%
- Check32 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check46 days agoChange DetectedThe page now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with an updated date of 2025-02-03, replacing the previous date of 2025-01-03.SummaryDifference6%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check68 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check75 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.